Brief: Illumina To Acquire Somalogic, Accelerating Its Proteomics Business
23/06/2025 12:16
June 23 (Reuters) - Illumina Inc ILMN.O: ILLUMINA TO ACQUIRE SOMALOGIC, ACCELERATING ITS PROTEOMICS BUSINESS AND ADVANCING THE COMPANY'S MULTIOMICS STRATEGY ILLUMINA INC - TO BUY SOMALOGIC FOR $350 MILLION PLUS $75 MILLION IN MILESTONES ILLUMINA INC - EXPECTS SOMALOGIC BUSINESS TO BE PROFITABLE IN 2027 Source text: ID:nPnbcNwfxa Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsBrief: Illumina Bioinsight Platform Expands With New Software To Accelerate The Path From Sequencing To Discovery
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Brief: Illumina To Announce Third Quarter 2026 Financial Results
Brief: Illumina Releases Spliceai2 To Help Advance Rare Disease Research